IP Library Granted Patent US 10,420,863
Granted Patent B2
US 10,420,863 · App. 15/840,461 · Granted Sep 24, 2019

Bioabsorbable polymeric composition for a medical device

Inventors: G. Lawrence Thatcher (Chelmsford, MA); Robert J. Cottone (Davie, FL)
Assignee: ORBUSNEICH MEDICAL PTE. LTD.
A61L31/148A61F2/82A61F2/915A61K9/10A61L27/18A61L27/26A61L27/58A61L31/06A61L31/14A61L31/16A61L31/18B29C45/0053B29C48/0022B29C71/0063C08G63/91C08L67/00A61F2210/0004A61L2300/412A61L2300/606B29C2793/009B29C2793/0018B29K2067/046B29K2105/0085B29K2995/006B29K2995/0041B29L2031/7534C08L2203/02C08L2205/02Y10T428/139Y10T428/1352
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,420,863
App. No.
15/840,461
Granted
Sep 24, 2019
Kind
B2
Abstract

A crystallized bioabsorbable polymer scaffold comprises a polymer composition of poly (L-lactide-co-tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) in the form of block copolymers of blocky copolymers, wherein the scaffold is cold-bendable.

Claims (27)

1. A crystallized bioabsorbable polymer scaffold comprising a polymer composition of poly (L-lactide-co-tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) in the form of block copolymers of blocky copolymers, wherein the scaffold is cold-bendable.

2. The bioabsorbable polymer scaffold of claim 1 , wherein the scaffold is cold bendable at temperatures in a range of about 10° C. to about 30° C.

3. The bioabsorbable polymer scaffold of claim 1 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone).

4. The bioabsorbable polymer scaffold of claim 1 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone).

5. The bioabsorbable polymer scaffold of claim 1 , further comprising a poly (L-lactide) moiety or a poly (D-lactide) moiety or a poly L-lactide-co-PEG moiety or a poly D-lactide-co-PEG moiety.

6. The bioabsorbable polymer scaffold of claim 1 , wherein the composition includes increased hydrophilicity and free molecular volume allowing for uptake of water.

7. The bioabsorbable polymer scaffold of claim 1 , wherein the composition includes amorphous and semicrystalline polymer portions.

8. The bioabsorbable polymer scaffold of claim 7 , wherein a crystallinity and tensile strength of the composition is adjustable by elongation of the semicrystalline portion.

9. The bioabsorbable polymer scaffold of claim 1 , further comprising at least one radiopaque marker.

10. A crystallized bioabsorbable polymer scaffold comprising a polymer composition of poly (L-lactide-co-tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) in the form of block copolymers of blocky copolymers, wherein the scaffold crystallizes in response to orthogonal strain.

11. The bioabsorbable polymer scaffold of claim 10 , wherein the scaffold includes struts that orient and crystallize in response to orthogonal strain upon deployment.

12. The bioabsorbable polymer scaffold of claim 10 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone).

13. The bioabsorbable polymer scaffold of claim 10 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone).

14. The bioabsorbable polymer scaffold of claim 10 , further comprising a poly (L-lactide) moiety or a poly (D-lactide) moiety or a poly L-lactide-co-PEG moiety or a poly D-lactide-co-PEG moiety.

15. The bioabsorbable polymer scaffold of claim 10 , wherein the composition includes increased hydrophilicity and free molecular volume allowing for uptake of water.

16. The bioabsorbable polymer scaffold of claim 10 , wherein the composition includes amorphous and semicrystalline polymer portions.

17. The bioabsorbable polymer scaffold of claim 10 , further comprising at least one radiopaque marker.

18. A crystallized bioabsorbable polymer scaffold comprising a polymer composition of poly (L-lactide-co-tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) wherein a contaminant monomeric residual fraction in the scaffold does not exceed about 0.5%.

19. The bioabsorbable polymer scaffold of claim 18 , wherein contaminant monomeric residual fraction in the scaffold does not exceed about 0.3%.

20. The bioabsorbable polymer scaffold of claim 18 , wherein contaminant monomeric residual fraction in the scaffold does not exceed about 0.2%.

21. The bioabsorbable polymer scaffold of claim 18 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone).

22. The bioabsorbable polymer scaffold of claim 18 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone).

23. The bioabsorbable polymer scaffold of claim 18 , further comprising a poly (L-lactide) moiety or a poly (D-lactide) moiety or a poly L-lactide-co-PEG moiety or a poly D-lactide-co-PEG moiety.

24. The bioabsorbable polymer scaffold of claim 18 , wherein the composition includes increased hydrophilicity and free molecular volume allowing for uptake of water.

25. The bioabsorbable polymer scaffold of claim 18 , wherein the composition includes amorphous and semicrystalline polymer portions.

26. The bioabsorbable polymer scaffold of claim 25 , wherein a crystallinity and tensile strength of the composition is adjustable by elongation of the semicrystalline portion.

27. The bioabsorbable polymer scaffold of claim 18 , further comprising at least one radiopaque marker.

Assignments (3)
CHANGE OF ADDRESS Recorded Jun 15, 2022
From: ORBUSNEICH MEDICAL PTE. LTD.
To: ORBUSNEICH MEDICAL PTE. LTD.
Reel/Frame 060386/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2019
From: THATCHER, G. LAWRENCE; COTTONE, ROBERT J.
To: ORBUSNEICH MEDICAL, INC.
Reel/Frame 048577/0235 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2019
From: ORBUSNEICH MEDICAL, INC.
To: ORBUSNEICH MEDICAL PTE. LTD.
Reel/Frame 048043/0879 →
Continuity (9)
Continuation 15457641 · Mar 13, 2017
Continuation 15298493 · Oct 20, 2016
Continuation 14542729 · Nov 17, 2014
Continuation 13370394 · Feb 10, 2012
Continuation 12508442 · Jul 23, 2009
Division 11781230 · Jul 20, 2007
Provisional Application 60862433 · Oct 20, 2006
Provisional Application 60807932 · Jul 20, 2006
Related Publication 20180099074A1 · Apr 12, 2018